Philip L Felgner Selected Research

Smallpox Vaccine (Vaccine, Smallpox)

5/2007	Proteome-wide analysis of the serological response to vaccinia and smallpox.
9/2005	Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip L Felgner Research Topics

Disease

61	Infections 01/2024 - 01/2005
44	Malaria 01/2024 - 07/2006
16	COVID-19 01/2023 - 01/2020
10	Communicable Diseases (Infectious Diseases) 01/2023 - 02/2010
7	Schistosomiasis (Bilharziasis) 11/2021 - 01/2010
6	Q Fever (Fever, Q) 01/2023 - 12/2008
6	Vaccinia 08/2014 - 01/2005
5	Human Influenza (Influenza) 08/2022 - 12/2018
5	Reinfection 01/2021 - 03/2014
5	Persistent Infection 01/2016 - 08/2010
5	Melioidosis 07/2011 - 01/2009
4	Leptospirosis 01/2021 - 01/2013
4	Typhoid Fever (Typhoid) 01/2017 - 01/2013
4	Brucellosis (Malta Fever) 01/2014 - 05/2010
3	Pneumonia (Pneumonitis) 01/2022 - 01/2011
3	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2018 - 07/2006
3	Tularemia 01/2016 - 06/2007
3	Toxoplasmosis 05/2015 - 02/2007
3	Tuberculosis (Tuberculoses) 09/2012 - 08/2010
2	Cerebral Malaria 01/2022 - 01/2018
2	Schistosomiasis haematobia (Schistosomiasis haematobium) 11/2021 - 01/2021
2	Bacteremia 01/2021 - 03/2012
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2020
2	Neoplasms (Cancer) 01/2021 - 01/2015
2	Bites and Stings (Sting) 03/2016 - 12/2013
2	Fever (Fevers) 03/2016 - 03/2014
2	Pemphigus (Pemphigus Vulgaris) 01/2013 - 02/2011
2	Neglected Diseases 01/2013 - 01/2009
1	Anemia 01/2022
1	Poliomyelitis (Polio) 01/2021
1	Bacillary Dysentery (Shigellosis) 01/2021
1	Papilloma (Papillomatosis) 01/2021
1	Tauopathies 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Chronic Traumatic Encephalopathy 01/2020
1	Virus Diseases (Viral Diseases) 12/2018

Drug/Important Bio-Agent (IBA)

78	AntigensIBA 01/2024 - 01/2005
70	Proteins (Proteins, Gene)FDA Link 10/2023 - 09/2005
48	VaccinesIBA 01/2024 - 01/2005
39	AntibodiesIBA 05/2023 - 10/2007
19	Immunoglobulin G (IgG)IBA 11/2021 - 07/2011
19	ProteomeIBA 01/2021 - 01/2005
11	Subunit VaccinesIBA 01/2021 - 01/2009
9	EpitopesIBA 10/2023 - 06/2008
9	Biomarkers (Surrogate Marker)IBA 11/2021 - 08/2010
9	Immunoglobulin M (IgM)IBA 01/2018 - 07/2011
8	Surface Antigens (Surface Antigen)IBA 10/2023 - 11/2011
6	Peptides (Polypeptides)IBA 10/2023 - 07/2011
6	Immunoglobulin A (IgA)IBA 09/2021 - 01/2016
4	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2024 - 12/2015
4	Neutralizing AntibodiesIBA 01/2023 - 09/2021
4	Malaria VaccinesIBA 10/2017 - 01/2015
3	Hemagglutinins (Hemagglutinin)IBA 08/2022 - 01/2019
3	CytokinesIBA 01/2022 - 07/2011
3	EnzymesIBA 01/2021 - 01/2014
3	Hemolysin Proteins (Hemolysins)IBA 06/2017 - 03/2014
3	Immunodominant EpitopesIBA 08/2014 - 05/2007
3	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 02/2007
2	Viral AntigensIBA 05/2023 - 09/2022
2	Praziquantel (Biltricide)FDA Link 01/2021 - 01/2015
2	NucleoproteinsIBA 01/2021 - 05/2020
2	ImmunosorbentsIBA 01/2021 - 03/2014
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2020
2	Chloroquine (Aralen)FDA LinkGeneric 01/2019 - 12/2013
2	Collodion (Nitrocellulose)IBA 01/2019 - 12/2008
2	LipopolysaccharidesIBA 06/2017 - 01/2016
2	Polysaccharides (Glycans)IBA 01/2017 - 01/2009
2	Recombinant ProteinsIBA 05/2015 - 01/2012
2	Interferon-gamma (Interferon, gamma)IBA 01/2014 - 07/2011
2	AutoantibodiesIBA 01/2013 - 02/2011
2	Immune Sera (Antisera)IBA 03/2012 - 01/2010
2	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 05/2007 - 09/2005
1	Amino Acids FDA Link 10/2023
1	Endothelial Protein C ReceptorIBA 10/2023
1	Formaldehyde (Formol)FDA Link 01/2023
1	MF59 oil emulsionIBA 08/2022
1	asoxime chloride (H16)IBA 08/2022
1	Vaccine AdjuvantsIBA 08/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	amotosalenIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	InterleukinsIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Messenger RNA (mRNA)IBA 11/2021
1	Immunologic Factors (Immunomodulators)IBA 09/2021
1	Disinfectants (Biocides)IBA 01/2021
1	FCPAIBA 01/2021
1	Combined VaccinesIBA 01/2021
1	AC133 AntigenIBA 01/2021
1	Tissue ExtractsIBA 01/2020
1	Single-Chain AntibodiesIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 08/2019
1	Cysteine (L-Cysteine)FDA Link 08/2019
1	Neuraminidase (Sialidase)IBA 01/2019
1	Type V Secretion SystemsIBA 01/2018
1	pertactin FDA Link 01/2018

Therapy/Procedure

6	Therapeutics 10/2023 - 01/2011
3	Immunotherapy 01/2022 - 10/2007
2	Mass Drug Administration 01/2017 - 03/2014
1	Chemoprevention 01/2019